SIGN UP FOR NEWSLETTER
February 14, 2019
Medical Tech Outlook Weekly Brief
Newsletter for Enterprise Technology Decision Makers
Feature of the Week
The study of biological functions & mechanisms enables the ability to introduce vertically ordered silicon nanoneedles into the cell membrane of an individual. Silicon nanoneedles arrange the cell membrane & inject the drugs directly into the body.
Cyber attacks on medical imaging devices will become a major challenge to device manufacturers and healthcare providers. The above methods must be practiced in order to better protect the devices from attacks.
Deep learning has great potential to reduce the turnaround time during the drug discovery process. Companies are leveraging predictive analytics insights from historical healthcare data, ML, and AI to design a personalized care regimen.
Featured Vendors
Global manufacturer of precision metal products.
A leading global partner to the pharma and healthcare industry for manufacturing and delivering specialty glass and plastic products.
Develops and produces customized components for customers, including tubing, catheters, and molded parts as well as complex groups of components and systems for diagnostic and therapeutic uses.
CIO Viewpoint
Kelly Summers, CHCIO, SVP & CIO, Maricopa Integrated Health System
We must look at automation, especially in the arena of discovery and technical entity relationships to aid us in managing our complex environments.
Michele C. D’Alessandro, VP & CIO, Manufacturing IT, Merck
Smart devices in the manufacturing setting provide a revolutionary way to connect operators to their work, and to each other, in real time.
CXO Insights
By Steve Venditti, Founder and CEO, Datum3D Product Development
We're starting to see automated robotic surgical systems designed to perform various minimally invasive surgeries.
By Timothy Korwan, Director of Integrated Solutions, Avantor
Biopharma manufacturers should conduct an ongoing evaluation of a single-use supplier's supply chain OpEx capabilities.
